Rehumanized Intervention for Self-Harm

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Florida State University

No Placebo Group

Approved in 4 Jurisdictions

Trial Summary

What is the purpose of this trial?

The goal of this experiment is to further determine if self-dehumanization is a novel risk factor for suicide. This study will reduce self-dehumanization using a novel re-humanization condition and compare this group to a control group to analyze the pathway between higher perceptions of self-dehumanization, suicidal ideation, and changes in oxytocin concentrations. It is hypothesized that participants randomly assigned to the re-humanized condition will exhibit decreases in suicidal ideation and increases in oxytocin concentrations as compared to the control condition, which will not display significant changes. Further, we will explore if the magnitude of the oxytocin response will partially mediate the change in suicidal ideation.

Eligibility Criteria

This trial is for individuals experiencing self-harm thoughts or behaviors, who are undergoing rehabilitation and treatment. Specific eligibility criteria details were not provided, so it's unclear who exactly can participate.

Inclusion Criteria

I am between 18 and 40 years old.

At least a moderate level of self-dehumanization (sum score of 12 or greater) and current suicidal ideation

I am a woman with a regular menstrual cycle lasting 26-30 days.

Exclusion Criteria

Participation in the Self-Dehumanized Study by this study team

I cannot fast for 10 hours due to a health condition.

Phobia of needles (trypanophobia)

Participant Groups

The study tests a new 'rehumanized' intervention aimed at reducing self-dehumanization against a control group to see if it affects suicidal ideation and oxytocin levels in the blood.

Group I: Rehumanized Intervention Experimental Treatment 4 Interventions

This self-rehumanization intervention will involve a set of multi-sensory activities (i.e., reading, writing, and speaking) to prompt body and soul awareness, agency, connection, and creativity.

Group II: Control Intervention Active Control 4 Interventions

Control Intervention about political attitudes

Oxytocin is already approved in United States, European Union, Canada, Australia for the following indications:

🇺🇸 Approved in United States as Pitocin for:

• Induction of labor
• Augmentation of labor
• Control of postpartum bleeding

🇪🇺 Approved in European Union as Syntocinon for:

• Induction of labor
• Augmentation of labor
• Control of postpartum bleeding

🇨🇦 Approved in Canada as Oxytocin for:

• Induction of labor
• Augmentation of labor
• Control of postpartum bleeding

🇦🇺 Approved in Australia as Oxytocin for:

• Induction of labor
• Augmentation of labor
• Control of postpartum bleeding

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Florida State University Tallahassee, FL

Who Is Running the Clinical Trial?

Florida State University Lead Sponsor

References